Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 12.67 USD -3.87% Market Closed
Market Cap: 966m USD

Intrinsic Value

NRIX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one NRIX stock under the Base Case scenario is 10.14 USD. Compared to the current market price of 12.67 USD, Nurix Therapeutics Inc is Overvalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NRIX Intrinsic Value
10.14 USD
Overvaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare NRIX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NRIX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Nurix Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nurix Therapeutics Inc

Current Assets 563.7m
Cash & Short-Term Investments 549.7m
Other Current Assets 14m
Non-Current Assets 51.3m
PP&E 44.8m
Other Non-Current Assets 6.5m
Efficiency

Free Cash Flow Analysis
Nurix Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nurix Therapeutics Inc

Revenue
56.4m USD
Operating Expenses
-287.1m USD
Operating Income
-230.7m USD
Other Expenses
22.3m USD
Net Income
-208.4m USD
Fundamental Scores

NRIX Profitability Score
Profitability Due Diligence

Nurix Therapeutics Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Net Margin is Increasing
Declining Operating Margin
Low 3Y Average Gross Margin
Low Gross Margin
13/100
Profitability
Score

Nurix Therapeutics Inc's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

NRIX Solvency Score
Solvency Due Diligence

Nurix Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
69/100
Solvency
Score

Nurix Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NRIX Price Targets Summary
Nurix Therapeutics Inc

Wall Street analysts forecast NRIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NRIX is 30.9 USD with a low forecast of 16.16 USD and a high forecast of 43.05 USD.

Lowest
Price Target
16.16 USD
28% Upside
Average
Price Target
30.9 USD
144% Upside
Highest
Price Target
43.05 USD
240% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Nurix Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NRIX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NRIX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one NRIX stock?

The intrinsic value of one NRIX stock under the Base Case scenario is 10.14 USD.

Is NRIX stock undervalued or overvalued?

Compared to the current market price of 12.67 USD, Nurix Therapeutics Inc is Overvalued by 20%.

Back to Top